Two balance-sheet ratios against market capitalisation and a test on the line of business, run across every listed US company over a billion dollars. Screened on AAOIFI’s limits, which are the strictest of the five published sets — a company clearing them clears the other four on these ratios as well.
Enter an ETF and every holding is put through the same screen as a company’s report. The result is the share of the fund’s money that passes, fails, or could not be screened — and how much each of the five standards would exclude on its own.
Needs live data. Fund holdings are read live; without a connection there is nothing to screen.
Invesco Pharmaceuticals ETF (PJP) is not a Shariah-compliant fund: 28.2% of its weight is in companies that fail the Shariah screen, through their line of business or their debt and cash. 65.4% passes and 6.4% could not be screened.
| Holding | Weight | Why |
|---|---|---|
| PFE Pfizer Inc | 5.4% | Debt 38.7% of market cap |
| VTRS Viatris Inc | 3.8% | Debt 56.6% of market cap |
| AMRX Amneal Pharmaceuticals Inc | 3.6% | Debt 42.8% of market cap |
| PBH Prestige Consumer Healthcare Inc | 2.8% | Debt 90.5% of market cap |
| BMY Bristol-Myers Squibb Co | 2.8% | Debt 34.6% of market cap |
| COLL Collegium Pharmaceutical Inc | 2.8% | Debt 136.8% of market cap |
| INVA Innoviva Inc | 2.7% |
Invesco Pharmaceuticals ETF (PJP) is not a Shariah-compliant fund: 28.2% of its weight is in companies that fail the Shariah screen, through their line of business or their debt and cash. 65.4% passes and 6.4% could not be screened.
65.4% of the fund's weight (16 of 29 holdings) is in companies that pass; 28.2% (9 holdings) fails; 6.4% (4 lines) could not be screened.
The largest are PFE (5.4%), VTRS (3.8%), AMRX (3.6%), PBH (2.8%), BMY (2.8%), COLL (2.8%), INVA (2.7%), HRMY (2.6%), among 9 in all. Banks, insurers, credit and asset managers, alcohol, tobacco and gambling are excluded on their business; the others carry debt or cash above 30% of their market value.
Funds with a Shariah mandate screen their holdings and purify their income: SPUS, HLAL, UMMA, SPTE, SPWO. Each has its own page here, with the same holding-by-holding check.
Each holding goes through the halal stock screener's test: interest-bearing debt and cash plus short-term investments each under 30% of market cap (AAOIFI's limits, the strictest of the five published sets), and a line of business that is not excluded. Holdings are as the fund reported them on November 17, 2026; companies listed outside the US, cash, bonds and derivatives are not screened.
Shariah funds checked the same way: Is SPUS halal?, Is HLAL halal?, Is UMMA halal?, Is SPTE halal?, Is SPWO halal?. All halal ETFs compared. Run all five published standards on this fund with the check below.
A mechanical screen of published financial ratios and each company's line of business, not a religious ruling. It does not test income from excluded activities; check with a scholar you trust.
| Cash and short-term investments 44.7% of market cap |
| HRMY Harmony Biosciences Holdings Inc | 2.6% | Cash and short-term investments 40.0% of market cap |
| OCUL Ocular Therapeutix Inc | 1.7% | Cash and short-term investments 39.1% of market cap |